These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 38375092)

  • 1. Cutaneous targets for topical pain medications in patients with neuropathic pain: individual differential expression of biomarkers supports the need for personalized medicine.
    Albrecht PJ; Liu Y; Houk G; Ruggiero B; Banov D; Dockum M; Day AJ; Rice FL; Bassani G
    Pain Rep; 2024 Apr; 9(2):e1119. PubMed ID: 38375092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Keratinocyte Biomarkers Distinguish Painful Diabetic Peripheral Neuropathy Patients and Correlate With Topical Lidocaine Responsiveness.
    Albrecht PJ; Houk G; Ruggiero E; Dockum M; Czerwinski M; Betts J; Wymer JP; Argoff CE; Rice FL
    Front Pain Res (Lausanne); 2021; 2():790524. PubMed ID: 35295428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment options in postherpetic neuralgia.
    Bonezzi C; Demartini L
    Acta Neurol Scand Suppl; 1999; 173():25-35; discussion 48-52. PubMed ID: 10819089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of chronic neuropathic pain with single and compounded topical analgesics.
    Knezevic NN; Tverdohleb T; Nikibin F; Knezevic I; Candido KD
    Pain Manag; 2017 Nov; 7(6):537-558. PubMed ID: 29125423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postherpetic Neuralgia: Current Evidence on the Topical Film-Forming Spray with Bupivacaine Hydrochloride and a Review of Available Treatment Strategies.
    Ngo AL; Urits I; Yilmaz M; Fortier L; Anya A; Oh JH; Berger AA; Kassem H; Sanchez MG; Kaye AD; Urman RD; Herron EW; Cornett EM; Viswanath O
    Adv Ther; 2020 May; 37(5):2003-2016. PubMed ID: 32297285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous nerve fiber and peripheral Nav1.7 assessment in a large cohort of patients with postherpetic neuralgia.
    Fetell M; Sendel M; Li T; Marinelli L; Vollert J; Ruggerio E; Houk G; Dockum M; Albrecht PJ; Rice FL; Baron R
    Pain; 2023 Nov; 164(11):2435-2446. PubMed ID: 37366590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Postherpetic Neuralgia with 5% Topical Lidocaine Plaster – Experience from a Small County Hospital: Case Report.
    Kontić M; Vičić-Hudorović V; Hudorović N
    Acta Clin Croat; 2016 Dec; 55(4):655-658. PubMed ID: 29117658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical capsaicin (high concentration) for chronic neuropathic pain in adults.
    Derry S; Sven-Rice A; Cole P; Tan T; Moore RA
    Cochrane Database Syst Rev; 2013 Feb; (2):CD007393. PubMed ID: 23450576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Treatment of Topical Drugs for Postherpetic Neuralgia: A Network Meta-Analysis.
    Liu X; Wei L; Zeng Q; Lin K; Zhang J
    Pain Physician; 2020 Nov; 23(6):541-551. PubMed ID: 33185370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical lidocaine gel relieves postherpetic neuralgia.
    Rowbotham MC; Davies PS; Fields HL
    Ann Neurol; 1995 Feb; 37(2):246-53. PubMed ID: 7847866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of 5% lidocaine (lignocaine) medicated plaster in comparison with pregabalin in patients with postherpetic neuralgia and diabetic polyneuropathy: interim analysis from an open-label, two-stage adaptive, randomized, controlled trial.
    Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M
    Clin Drug Investig; 2009; 29(4):231-41. PubMed ID: 19301937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost effectiveness of a lidocaine 5% medicated plaster compared with pregabalin for the treatment of postherpetic neuralgia in the UK: a Markov model analysis.
    Ritchie M; Liedgens H; Nuijten M
    Clin Drug Investig; 2010; 30(2):71-87. PubMed ID: 20067326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosing and managing postherpetic neuralgia.
    Nalamachu S; Morley-Forster P
    Drugs Aging; 2012 Nov; 29(11):863-9. PubMed ID: 23038608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of lidocaine as a topical analgesic and improvements in patch delivery systems.
    Gudin J; Nalamachu S
    Postgrad Med; 2020 Jan; 132(1):28-36. PubMed ID: 31900074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postherpetic neuralgia: topical lidocaine is effective in nociceptor-deprived skin.
    Wasner G; Kleinert A; Binder A; Schattschneider J; Baron R
    J Neurol; 2005 Jun; 252(6):677-86. PubMed ID: 15778907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical lidocaine for neuropathic pain in adults.
    Derry S; Wiffen PJ; Moore RA; Quinlan J
    Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD010958. PubMed ID: 25058164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical capsaicin (high concentration) for chronic neuropathic pain in adults.
    Derry S; Rice AS; Cole P; Tan T; Moore RA
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD007393. PubMed ID: 28085183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An update on the pharmacological management of post-herpetic neuralgia and painful diabetic neuropathy.
    Zin CS; Nissen LM; Smith MT; O'Callaghan JP; Moore BJ
    CNS Drugs; 2008; 22(5):417-42. PubMed ID: 18399710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical Treatments and Their Molecular/Cellular Mechanisms in Patients with Peripheral Neuropathic Pain-Narrative Review.
    Kocot-Kępska M; Zajączkowska R; Mika J; Kopsky DJ; Wordliczek J; Dobrogowski J; Przeklasa-Muszyńska A
    Pharmaceutics; 2021 Mar; 13(4):. PubMed ID: 33810493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postherpetic neuralgia: New hopes in prevention with adult vaccination and in treatment with a concentrated capsaicin patch.
    Gawecka E; Viken O
    Scand J Pain; 2012 Oct; 3(4):220-228. PubMed ID: 29913873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.